New Late-Breaking Results from Phase 3 Trials of SKYRIZI® (risankizumab) Evaluating Long-term Effect on Skin and Joint Symptoms in Patients with Psoriatic Arthritis at Week 100 ...Middle East

- Analyses included 100-week efficacy and safety data from the four-year, open-label extension period of KEEPsAKE 1 and 2 evaluating SKYRIZI in patients with active psoriatic arthritis1 - Ongoing treatment with SKYRIZI demonstrated consistent long-term efficacy in psoriatic arthritis with...

Hence then, the article about new late breaking results from phase 3 trials of skyrizi risankizumab evaluating long term effect on skin and joint symptoms in patients with psoriatic arthritis at week 100 was published today ( Saturday 10/09/2022 - 10:32 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New Late-Breaking Results from Phase 3 Trials of SKYRIZI® (risankizumab) Evaluating Long-term Effect on Skin and Joint Symptoms in Patients with Psoriatic Arthritis at Week 100 )

Also on site :

• In 2008, Celine Dion bought a lot on Florida’s Jupiter Island for $7 million; her water park mansion there sold 9 years later for $28 million
• Dwayne Johnson and Oprah Winfrey gave $10 million to launch the People’s Fund of Maui for wildfire survivors
• In 2017, Jack Daniel’s named Nathan “Nearest” Green its first master distiller for teaching the brand’s founder to distill whiskey over a century earlier